Skip to main content
Top

Calcified Tissue International

Issue 4/2000

Content (17 Articles)

Ossification Centers of Human Femur

G. L. Panattoni, P. D'Amelio, M. Di Stefano, G. C. Isaia

Bone Mineral Density and Biochemical Markers of Bone Turnover in Peri- and Postmenopausal Women

V. De Leo, A. Ditto, A. la Marca, D. Lanzetta, C. Massafra, G. Morgante

Effect of Age on the Expression of Pex (Phex) in the Mouse

R. A. Meyer, Jr., C. G. Young, M. H. Meyer, P. L. Garges, D. K. Price

Comparison of Radiographic and pQCT Analyses of Healing Rat Tibial Fractures

T. Jämsä, A. Koivukangas, K. Kippo, R. Hannuniemi, P. Jalovaara, J. Tuukkanen

Exercise and Mechanical Loading Increase Periosteal Bone Formation and Whole Bone Strength in C57BL/6J Mice but Not in C3H/Hej Mice

Y. Kodama, Y. Umemura, S. Nagasawa, W. G. Beamer, L. R. Donahue, C. R. Rosen, D. J. Baylink, J. R. Farley

The Stimulation of Vertebral and Tibial Bone Growth by the Parathyroid Hormone Fragments, hPTH-(1-31)NH2, [Leu27]cyclo(Glu22-Lys26)hPTH-(1-31)NH2, and hPTH-(1-30)NH2

J. F. Whitfield, P. Morley, L. Fraher, A. B. Hodsman, D. W. Holdsworth, P. H. Watson, G. E. Willick, J.-R. Barbier, M. Gulam, R. J. Isaacs, S. MacLean, V. Ross

Low Dietary Protein and Low Bone Density

J. E. Kerstetter, A. C. Looker, K. L. Insogna

Book Review

Shared care for osteoporosis

Norman H. Bell

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine